Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2021 or the DISARM Act of 2021
This bill requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations. Additionally, the Government Accountability Office must report on the barriers to developing such antimicrobial drugs and must recommend ways to address such barriers.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2021-06-25 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2021-06-24 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2021-06-24 | IntroReferral | Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2021-06-24 | IntroReferral | Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2021-06-24 | IntroReferral | Introduced in House | Library of Congress |